4.5 Article

Late phase endothelial cell inflammation is characterized by interferon response genes and driven by JAK/STAT, not NF kappa B

Journal

VASCULAR PHARMACOLOGY
Volume 146, Issue -, Pages -

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.vph.2022.107090

Keywords

Endothelial cell; Inflammation; JAK; STAT; NF kappa B; p38; JNK

Funding

  1. International Society of Heart and Lung Transplantation and Enduring Hearts [the Norman E. Shumway Career Development Award]
  2. University of California, Los Angeles [Faculty Career Development Award]
  3. National Institutes of Health [R01-AI135201 01A1 2018-2023, U01AI136816]

Ask authors/readers for more resources

Chronic vascular inflammation is the basis of many diseases, and resolving inflammation is crucial for restoring homeostasis. Research shows that chronic activation is JAK1/2-dependent and characterized by adaptive chemokines.
Chronic vascular inflammation underlies many diseases, including atherosclerosis, autoimmune vasculitides and transplant rejection. The resolution of inflammation is critical for proper healing and restoration of homeostasis, but the timing and signaling mechanisms involved in the return to a non-inflamed state are not well understood. Pro-adhesive gene expression, phenotype and secretome of human endothelial cells was measured in primary human aortic endothelium under chronic TNF alpha stimulation, and after short-term TNF alpha priming followed by withdrawal. The effects of NF kappa B, MAPK and JAK1/2 inhibitors on TNF alpha-induced gene expression were tested. The majority of inducible TNF alpha effectors, such as E-selectin, VCAM-1 and most chemokines, required continuous exposure for reinforcement of the altered phenotype, and were NF kappa B dependent. However, 3 h priming with TNF alpha induced late phase STAT activation and interferon response genes after 18 h, as well as enhanced ICAM-1, BST2 and CXCR3 ligand expression. Chronic activation was autonomous of continuous TNF alpha, and could be blocked by the JAK1/2 inhibitor ruxolitinib. The results demonstrate that NF kappa B is not a significant driver of the later phase of endothelial cell activation by TNF alpha, but that sustained inflammation is JAK1/2-dependent and characterized by adaptive chemokines.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available